Article Details
Retrieved on: 2025-01-23 20:09:05
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses EXUMA Biotech's Phase 1 trial results for a HER2-targeted CAR-T cell therapy, promising in treating HER2-positive cancers including breast cancer. It ties to 'Biotech' through innovative cell therapy advancements by EXUMA Biotech Corp. Tags are related through cancer-specific technology targeting HER2-positive tumors using CAR T cells.
Article found on: www.kilgorenewsherald.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here